Monashee Investment Management LLC boosted its stake in shares of Pliant Therapeutics, Inc. (NASDAQ:PLRX – Get Rating) by 50.0% during the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor owned 150,000 shares of the company’s stock after purchasing an additional 50,000 shares during the period. Pliant Therapeutics comprises approximately […]
Shares of Pliant Therapeutics, Inc. (NASDAQ:PLRX – Get Rating) have earned an average rating of “Buy” from the eleven brokerages that are currently covering the company, Marketbeat reports. Eight investment analysts have rated the stock with a buy recommendation. The average 1-year price target among analysts that have updated their coverage on the stock in […]
Pliant Therapeutics, Inc. (NASDAQ:PLRX – Get Rating) shares were down 5.1% during trading on Monday . The stock traded as low as $21.73 and last traded at $21.77. Approximately 1,191,632 shares changed hands during mid-day trading, an increase of 38% from the average daily volume of 864,987 shares. The stock had previously closed at $22.94. […]
Pliant Therapeutics (NASDAQ:PLRX – Get Rating) had its target price boosted by Cantor Fitzgerald from $52.00 to $63.00 in a research report released on Monday morning, The Fly reports. Cantor Fitzgerald also issued estimates for Pliant Therapeutics’ FY2023 earnings at ($2.39) EPS. Other equities research analysts have also issued research reports about the company. Citigroup […]
Pliant Therapeutics (NASDAQ:PLRX – Get Rating) had its target price boosted by HC Wainwright from $54.00 to $55.00 in a research note published on Monday, The Fly reports. HC Wainwright also issued estimates for Pliant Therapeutics’ Q1 2023 earnings at ($0.61) EPS, Q2 2023 earnings at ($0.60) EPS, Q3 2023 earnings at ($0.64) EPS, Q4 […]